Isthmus Partners’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
RP
Isthmus Partners's ACLS Position: Q2 2026 in Review
Isthmus Partners reduced its Axcelis (ACLS) stake by 40% in Q2 2026, selling an estimated $2.34M and leaving 23,594 shares worth $4.47M. The position accounts for 0.43% of the portfolio, ranked #65.
Isthmus Partners first reported a position in ACLS in Q1 2024 and has held it in 10 quarters since. The position peaked at $4.73M in Q2 2024. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.
- Isthmus Partners held 23,594 shares of Axcelis worth $4.47M as of Q2 2026.
- Isthmus Partners sold 15,763 Axcelis shares in Q2 2026, an estimated $2.34M.
- Axcelis made up 0.43% of Isthmus Partners's portfolio in Q2 2026, its #65 holding.
- Isthmus Partners first reported a position in Axcelis in Q1 2024 and has held it in 10 quarters since.
- Isthmus Partners's Axcelis position peaked at $4.73M in Q2 2024.
- 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.
Based on Isthmus Partners's 13F filing for Q2 2026, filed 20 Jul 2026.